Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Affirms Outperform Rating for First Western Financial with Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finance_ Stock Charts (2)
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

On March 11, 2024, Wood Lay, an analyst at Keefe, Bruyette & Woods, affirmed an Outperform rating for First Western Financial (NASDAQ: MYFW) while revising the price target downward from $26 to $25. This update is based on Lay’s evaluation of the company’s performance and current market environment.

MYFW Stock Price Declines by 2.33% on March 11, 2024 – Investors Advised to Monitor Movement

On March 11, 2024, MYFW stock experienced a decline in its price performance, closing at $14.24. This represents a decrease of $0.34 from the previous market close, reflecting a 2.33% drop in value. MYFW is currently trading near the bottom of its 52-week range and is below its 200-day simple moving average. Despite the drop in price during regular trading hours, MYFW stock remained unchanged in after-hours trading. Investors and analysts may want to keep an eye on MYFW stock to see if it continues to trade near the bottom of its 52-week range or if there are any potential catalysts that could drive a change in its price momentum.

MYFW Stock Performance and Financial Results Analysis – March 11, 2024

On March 11, 2024, MYFW stock experienced mixed performances as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, MYFW’s total revenue for the past year was $168.30 million, which represented a 30.89% increase from the previous year. However, the total revenue for the fourth quarter was $44.08 million, which remained flat compared to the previous quarter.

In terms of net income, MYFW reported a net income of $8.70 million for the past year, marking a 59.91% decrease from the previous year. The net income for the fourth quarter was $255,000, showing a significant 91.82% decrease from the previous quarter. These declines in net income indicate potential challenges that MYFW may be facing in terms of profitability and operational efficiency.

Unfortunately, the earnings per share (EPS) for MYFW is currently unavailable, as there is not enough data to create an insight. EPS is an important metric that investors use to evaluate a company’s profitability and growth potential, so the lack of this information may impact investor sentiment towards MYFW stock.

Overall, the mixed performances of MYFW stock on March 11, 2024, highlight the importance of closely monitoring a company’s financial results and key metrics to make informed investment decisions. Investors should pay attention to future earnings reports and updates from MYFW to assess the company’s financial health and growth prospects.

Tags: MYFW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Insurance Markets and money (3)

Encova Insurance Embraces Digital Transformation with Guidewire Cloud

Finances (2)

Analyst Ratings and Price Targets for Nerdwallet March 11 2024

ICU Eyewear Holdings Inc Expands Partnership with US Retailer Adding 300 New Locations

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com